Amneal Pharmaceuticals
AMRX · NASDAQ
Bulios Fair Price
$13.99
22.6% downside
Current Price
$18.08
According to Bulios Fair Price, AMRX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Amneal Pharmaceuticals, Inc. is an American pharmaceutical company focused on the development, manufacturing, and distribution of generic and specialty medications. The company specializes in a broad range of therapeutic areas, including cardiovascular diseases, neurological disorders, oncology, and more. Amneal also produces its own branded products targeting specific conditions. The company is known for its ability to provide affordable medications while continuing to develop innovative therapies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chirag K. Patel
Employees
8,700
Headquarters
Bridgewater
Upcoming events
Earnings
Upcoming earnings report